Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cermak, R.
Right arrow Articles by Wolffram, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cermak, R.
Right arrow Articles by Wolffram, S.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:2802-2807, September 2003


Nutrient Metabolism

The Bioavailability of Quercetin in Pigs Depends on the Glycoside Moiety and on Dietary Factors1,2

Rainer Cermak3, Sandra Landgraf and Siegfried Wolffram

Institute of Animal Nutrition, Physiology and Metabolism, Christian-Albrechts-University Kiel, D-24098 Kiel, Germany

3To whom correspondence should be addressed. E-mail: cermak{at}aninut.uni-kiel.de.

Recent investigations suggest that the bioavailability of quercetin depends on the glycoside moiety of the quercetin glycosides present in the diet. In this study, we compared the oral bioavailability of quercetin from quercetin aglycone and two different quercetin glycosides in pigs. Pigs were equipped with permanent catheters in the jugular and portal veins. After consumption of a test meal containing the respective compounds, blood samples were drawn repeatedly over a period of 24 h and analyzed by HPLC. In a first set of experiments, pigs received a single oral dose of 148 µmol/kg body (equivalent to 50 mg/kg) provided as quercetin aglycone, quercetin-3-O-glucoside (Q3G) or quercetin-3-O-glucorhamnoside (rutin) as part of their diet. The main metabolite in plasma was always conjugated quercetin, whereas free quercetin was not detected in either the jugular or the portal blood. For Q3G and rutin, the relative total bioavailability of quercetin (i.e., conjugated quercetin and conjugated methylethers of quercetin) was 148% (P = 0.07) and 23% (P < 0.05), respectively, compared with quercetin aglycone. In another experiment with a dose of 29.6 µmol/kg (equivalent to 10 mg/kg), the relative total bioavailability of Q3G was 167% compared with the aglycone (P < 0.05). Bioavailability of Q3G was significantly higher when the test meal was ground beef rather than the standard ration. Our results indicate that the bioavailability of quercetin from quercetin glycosides is determined by a complex interdependence between the chemical form of the flavonols and dietary factors.


KEY WORDS: • flavonoids • bioavailability • quercetin • isoquercitrin • rutin




This article has been cited by other articles:


Home page
J. Nutr.Home page
B. A. Graf, C. Ameho, G. G. Dolnikowski, P. E. Milbury, C.-Y. Chen, and J. B. Blumberg
Rat Gastrointestinal Tissues Metabolize Quercetin
J. Nutr., January 1, 2006; 136(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
B. A. Graf, W. Mullen, S. T. Caldwell, R. C. Hartley, G. G. Duthie, M. E. J. Lean, A. Crozier, and C. A. Edwards
DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4'-GLUCOSIDE IN RATS
Drug Metab. Dispos., July 1, 2005; 33(7): 1036 - 1043.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. C. J. de Boer, A. A. Dihal, H. van der Woude, I. C. W. Arts, S. Wolffram, G. M. Alink, I. M.C.M. Rietjens, J. Keijer, and P. C. H. Hollman
Tissue Distribution of Quercetin in Rats and Pigs
J. Nutr., July 1, 2005; 135(7): 1718 - 1725.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Lesser, R. Cermak, and S. Wolffram
Bioavailability of Quercetin in Pigs Is Influenced by the Dietary Fat Content
J. Nutr., June 1, 2004; 134(6): 1508 - 1511.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]